Multiple Vertebral Osteonecroses (Kümmell's Disease) After 10 Years on Denosumab: Is Osteocyte Apoptosis to Blame?

Calcif Tissue Int. 2018 Mar;102(3):368-372. doi: 10.1007/s00223-017-0357-1. Epub 2017 Nov 4.

Abstract

We report here a case of multiple vertebral osteonecroses with intrasomatic gaseous dissection (Kümmell's disease) occurring 1 year after the end of a 10-year course of denosumab treatment for osteoporosis without fractures. Histomorphometry and bone remodeling markers revealed major bone resorption and the persistence of an inhibition of bone formation. The presence of multiple empty lacunae in the bone provided evidence for high levels of osteocyte apoptosis. Osteocytes direct bone resorption (via the RANK/RANK-L/osteoprotegerin system) and formation (Wnt system, with SOST and DKK1) pathways. The vertebral osteonecrosis in our case may, therefore, have resulted from osteocyte apoptosis, decompensated by the sudden reactivation of bone remodeling after the cessation of denosumab treatment.

Keywords: Denosumab; Osteocyte apoptosis; Osteoporosis; Vertebral osteonecrosis.

MeSH terms

  • Aged, 80 and over
  • Apoptosis / drug effects*
  • Bone Remodeling / drug effects
  • Bone and Bones / drug effects
  • Denosumab / adverse effects*
  • Denosumab / therapeutic use
  • Female
  • Humans
  • Osteocytes / drug effects*
  • Osteocytes / pathology
  • Osteonecrosis / diagnosis
  • Osteonecrosis / etiology*
  • Osteonecrosis / pathology
  • Spinal Fractures / diagnosis
  • Spinal Fractures / drug therapy*
  • Spine / drug effects
  • Spine / pathology

Substances

  • Denosumab